In extensive hepatic disease, which change commonly leads to prolonged PT and PTT?

Study liver anatomy and function with our medical students test. Engage with detailed multiple choice questions, each with hints and explanations. Prepare effectively for your test!

Multiple Choice

In extensive hepatic disease, which change commonly leads to prolonged PT and PTT?

In extensive hepatic disease, the main determinant of prolonged PT and PTT is the liver’s reduced ability to synthesize clotting factors. The liver makes most of the coagulation proteins, including factors II, VII, IX, and X, that drive both the extrinsic (PT) and intrinsic (PTT) pathways of the cascade. When their production falls, the cascades slow down at multiple steps, so both PT and PTT become longer. Factor VII, which feeds the extrinsic pathway, has a relatively short half-life, so PT often shows prolongation earlier in liver disease. As the disease advances and other factors (II, IX, X, and others) decline, the intrinsic pathway is also affected, causing a more pronounced or later PTT prolongation. While bilirubin can be elevated in liver dysfunction, it is not the direct cause of longer PT/PTT; the crucial issue is decreased clotting factor production. Platelet changes can affect bleeding risk, but they do not explain the stepwise prolongation of these clotting times the way reduced factor synthesis does.

In extensive hepatic disease, the main determinant of prolonged PT and PTT is the liver’s reduced ability to synthesize clotting factors. The liver makes most of the coagulation proteins, including factors II, VII, IX, and X, that drive both the extrinsic (PT) and intrinsic (PTT) pathways of the cascade. When their production falls, the cascades slow down at multiple steps, so both PT and PTT become longer.

Factor VII, which feeds the extrinsic pathway, has a relatively short half-life, so PT often shows prolongation earlier in liver disease. As the disease advances and other factors (II, IX, X, and others) decline, the intrinsic pathway is also affected, causing a more pronounced or later PTT prolongation. While bilirubin can be elevated in liver dysfunction, it is not the direct cause of longer PT/PTT; the crucial issue is decreased clotting factor production. Platelet changes can affect bleeding risk, but they do not explain the stepwise prolongation of these clotting times the way reduced factor synthesis does.

More practice questions